|
0730-1500
|
|
Semi-Live Surgery
Co-Chairs: Melanie Aube-Peterkin, Canada / Jean de la Rosette, Turkey / Rafael Sanchez-Salas, Canada
|
|
Semi Live Surgery Course Learning Objectives:
At the end of this course, participants should be able to:
- Recognize important perioperative considerations and techniques for reconstructive urologic surgery, including selecting the best reconstructive approach to optimize treatment outcomes.
- Demonstrate practical knowledge of instrumentation and techniques for the endourologic treatment of upper and lower urinary tract conditions, including the management of special clinical cases.
- Examine the role of micro-ultrasound and focal therapy approaches in the management of radiorecurrent prostate cancer.
- Recognize the advantages and limitations of open surgery, laparoscopic, and robotic-assisted procedures in uro-oncology, with respect to novel devices, instrumentation, and techniques.
- Evaluate their own role in patient management, from multidisciplinary care to treatment outcomes, based on the clinical experience of key opinion leaders in the surgical management of urologic conditions.
|
|
0730-0945
|
|
Reconstructive Surgery
Moderator: Melanie Aube-Peterkin, Canada
|
|
|
|
Procedures:
|
|
|
|
Vaginal reconstruction with autologous sling
|
|
|
|
Penile urethroplasty: Kulkarni technique
Surgeon: Sanjay Kulkarni, India
|
|
|
|
Penile prosthesis implantation: AMS
Surgeon: Daniel Rosenstein, United States
|
|
|
|
Penile prosthesis implantation: Titan
Surgeon: Koenraad van Renterghem, Belgium
|
|
|
|
Urethral strictures: Optilume
Surgeon: Merycarla Pichardo, Dominican Republic
|
|
|
|
Holmium laser bladder neck incision
Surgeon: Ramon Virasoro, United States
|
|
0945-1115
|
|
Focal Therapy and Imaging in Radiorecurrent Disease
Moderator: Jurgen Futterer, The Netherlands
|
|
|
|
Procedures:
|
|
|
|
Micro-Ultrasound
|
|
|
|
Cryotherapy
|
|
|
|
HIFU, Focal One
|
|
1115-1330
|
|
Endourology
Moderator: Ben Chew, Canada
|
|
|
|
Procedures:
|
|
|
|
Prostate enucleation: HoLEP en-bloc procedure +/- low-power HoLEP vs. Soltive ThuFLEP and bladder stone dusting
|
|
|
|
HoLEP
|
|
|
|
ThuFLEP
Surgeon: Naeem Bhojani, Canada
|
|
|
|
Stones: Focus on Special Cases
|
|
|
|
PCNL in an obese patient
|
|
|
|
PCNL in pediatric patients
Surgeon: Sanjay Khadgi, Nepal
|
|
|
|
Single-use ureteroscope for stone management
|
|
|
|
Different access sheaths for PCNL
|
|
|
|
Thulium fiber laser for kidney stones
Surgeon: Dimitry Enikeev, Russia
|
|
1330-1500
|
|
Uro-Oncology
Moderator: Pilar Laguna, Turkey
|
|
|
|
Simulation Training
Surgeon: Gonzalo Vitagliano, Argentina
|
|
|
|
Open vs. robotic vs. laparoscopic - three procedures presented simultaneously.
|
|
|
|
Open
Surgeon: Gennady Bratslavsky, United States
|
|
|
|
Robotic
Surgeon: Elias Bodden, Germany
|
|
|
|
Laparoscopic
Surgeon: Petr Macek, France
|
|
|
|
Robotic radical prostatectomy
Surgeon: Ruben Olivares, United States
|
|
|
0800-0930
|
|
Instructional Course: Evaluation and Management of Non-neurogenic Female Bladder Outlet Obstruction (BOO)
Chair: Lysanne Campeau, Canada
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the pathophysiology of female BOO
- Describe the various causes of female BOO
- Carry out appropriate investigations for female BOO
- Describe various medical treatment of female BOO
- Describe various surgical treatments of female BOO
|
|
0800-0803
|
|
Introduction and Welcome
Lysanne Campeau, Canada
|
|
0803-0808
|
|
Evaluation of female patients with BOO (History, physical examination and basic investigations)
|
|
0808-0820
|
|
Discussion
|
|
0820-0827
|
|
Differential diagnosis of Female BOO
|
|
0827-0832
|
|
Advanced Evaluation (Video urodynamics, and cystoscopy) in female BOO
|
|
0832-0844
|
|
Discussion
|
|
0844-0854
|
|
Conservative and medical management of Female BOO
|
|
0854-0904
|
|
Surgical management of Female BOO
|
|
0904-0928
|
|
Cases for interaction and discussion
|
|
0928-0930
|
|
Wrap up and Evaluation
|
|
|
0800-0930
|
|
Instructional Course: Male Infertility and Assisted Reproductive Technology
|
|
0800-1000
|
|
Canadian Urological Association (CUA) Symposium
|
|
0800-1000
|
|
Interactive Session: Bladder Pain Syndrome and Interstitial Cystitis
Co-Chairs: Roger Dmochowski, United States / Rajesh Taneja, India
|
|
Learning Objectives:
At the end of this session, participants should be able to:
- To introduce the topic, which is usually much less discussed than required. Since this is a disease which is primarily a clinical diagnosis, and the one which is made by exclusion of other diseases, it is important to sensitize the clinicians about the real-world scenario. The prevalence estimates range from 2.7% to 6.53% in women of age 18 years or older in the United States to 306/100 000 women in Vienna (1,2)
- The nomenclature of this disease entity has been evolving. We need to have a balanced approach to discuss how it is perceived in various parts of world (3)
- These are heterogenous group of patients and consequently the etiopathogensis of the symptoms is variable. Through this symposium, an attempt would be made to discuss the varied pathogenic mechanism leading to the clinical picture. (4 )
- Since this is a heterogeneous entity, no single modality of treatment is likely to benefit these patients. An outline of treatment modalities, along with some newer methods including self-intravesical instillations will be discussed. ( 5,6)
|
|
|
|
1. Nomenclature of bladder pain syndrome – the concept of Hypersensitive Bladder
|
|
|
|
2. Pathophysiology of IC/BPS
|
|
|
|
3. Clinical Approach to a suspected IC/BPS
|
|
|
|
4. Cystoscopy in IC /BPS
Shingai Mutambirwa, South Africa
|
|
|
|
5. Management of IC/BPS
|
|
|
|
6. Self help in intravesical treatment. What is on the horizon
Sandor Lovasz, Hungary
|
|
|
|
Interactive panel discussion
|
|
|
0800-1000
|
|
SIU Tips and Tricks - Pt 1 SIU Academy
Chair: Faysal Yafi, United States
|
|
0800-1000
|
|
Workshop: Basics in Endourology (For the Beginners)
Coordinators: Belthangady Monu Zeeshan Hameed, India / Dilip Mishra, India / Amelia Pietropaolo, United Kingdom
|
|
0800-1200
|
|
International Consultation on Urological Diseases (ICUD) and World Urologic Oncology Federation (WUOF) - Consultation: Kidney Cancer
|
|
0800-1200
|
|
Joint International Society of Reconstructive Urology (ISORU) & Society of Genitourinary Reconstructive Surgeons (GURS) Symposium
|
|
1000-1130
|
|
Instructional Course: Novel BPH Therapies – Review of Technologies and Practical Instruction (Laser EEP, UroLift, Rezum, Aquablation, Stents)
Co-Chair: Dean Elterman, Canada
|
|
Learning Objectives:
At the end of the session, attendees will be able to:
- Understand the mechanism of action and technique for each of the novel BPH therapies
- Select the best patients for each procedure type based upon patient and prostate characteristics
- Gain knowledge of the clinical data supporting the use of each modality
- Understand best-practice technique for each modality based upon the literature and expert opinion
- Gain an appreciation for the challenges encountered and troubleshooting for each technology
- Appreciate the “tips & tricks” provided by the experts for performing these novel BPH therapies.
Faculty:
- Enrique Rijos, Barcelona
- Vincent Misrai, Toulouse
- Kevin C. Zorn, Canada
- Naeem Bhojani, Canada
- Vineet Gauhar, Singapore
- Bilal Chughtai, United States
|
|
|
|
1000-1130
|
|
Instructional Course: Testosterone Replacement Therapy: An Update on What You Need to Know for Safe Prescribing in Men with Pre-existing Prostate and Cardiovascular Disease and the Impact of COVID-19
|
|
1000-1200
|
|
Interactive Session: Medico-Legal Aspects in Urology: Global Challenges
Co-Chair: Rajeev T P, India
|
|
1000-1200
|
|
Joint SIU - Korean Urological Association (KUA) Symposium
Co-Chairs: Christopher Evans, United States / Sung Kyu Hong, South Korea
|
|
1000-1200
|
|
Joint SIU-Confederación Americana de Urología (CAU) Session (in English)
|
|
1000-1200
|
|
SIU Tips and Tricks - Pt 2 SIUJ - Tips & Tricks in Urologic Publishing
Chair: Peter Black, Canada
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Recognize the pros and cons of open access publishing and open peer review
- Identify the requisite characteristics of a reputable journal and distinguish such journals from predatory journals
- Understand the components of a high-quality peer review of a journal article
|
|
1000-1005
|
|
Introduction
Peter Black, Canada
|
|
1005-1020
|
|
Urologic Publishing in 2022
|
|
1020-1045
|
|
Controversies in Urologic Publishing - Roundtable Discussion
Moderator: Peter Black, Canada
|
|
1045-1100
|
|
Q&A
|
|
1100-1120
|
|
Recognizing and Avoiding Pseudojournals in Urology
|
|
1120-1130
|
|
Q&A
|
|
1130-1150
|
|
Tips & Tricks for Peer Review
|
|
1150-1155
|
|
Q&A
|
|
1155-1200
|
|
Closing remarks
|
|
|
1000-1200
|
|
Workshop: Laparoscopy for Beginners (EBLUS Curriculum )
Coordinators: Bhavan Rai Prasad, United Kingdom / Rajan Veeratterapillay, United Kingdom
|
|
1300-1430
|
|
Instructional Course: Varicocele and Male Infertility: Uncovering the Facts by an Evidence Based Approach
|
|
1300-1430
|
|
Instructional Course: Virtual Care,TeleUrology, Digital Health - Full Complement of Patient-Centred Urologic Care: The Time Is Now!
Chair: Emmanuel Abara, Canada
|
|
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the path we have travelled with Virtual Care.TeleUrology .Digital Health and the Future.
- Analyze the needs of our patients, the services we can provide and the balance.
- Create Guidelines with appropriate resources available and region sensitive.
- Understand various Regulatory, Legal ,Patient Privacy issues, Re-imbursement patterns -world-wide ,with some examples.
- Enumerate some Challenges and Opportunities in Virtual Care TeleUrology.Digital Health and how we can close gaps and disparities.
|
|
1300-1303
|
|
Welcome and Introduction
Emmanuel Abara, Canada
|
|
1303-1315
|
|
Where did we come from? Where are we? Where are we heading to?
Emmanuel Abara, Canada
Zaki Almallah, United Arab Emirates
|
|
1315-1319
|
|
Q&A
|
|
1319-1331
|
|
What do our patients need or want? What can we offer them? Where is the balance? A role for Guidelines appropriate with resources?
Sunil Shroff, India
|
|
1331-1335
|
|
Q&A
|
|
1335-1347
|
|
What Regulatory Processes, Legal Aspects, Policy Affairs and Re-imbursement 'hurdles' should we be aware of?
Aaron D. Martin, United States
|
|
1347-1351
|
|
Q&A
|
|
1351-1403
|
|
Teleurology Implementation: Practical Points, Different Places and Perspectives?
Zaki Almallah, United Arab Emirates
|
|
1403-1407
|
|
Q&A
|
|
1407-1419
|
|
What are the Challenges and Opportunities for Virtual Care. TeleUrology. Digital Health: Now and Going Forward?
Emmanuel Abara, Canada
|
|
1419-1423
|
|
Q&A
|
|
1423-1430
|
|
Summary / Take Home Message
|
|
|
1300-1500
|
|
Interactive Session: Recurrent UTIs
Chair: Bhaskar K. Somani, United Kingdom
|
|
1300-1500
|
|
Interactive Session: Women in Urology - Leading the Way!
Co-Chairs: Caroline Moore, United Kingdom / Amelia Pietropaolo, United Kingdom / G Laxman Prabhu, India
|
|
1300-1500
|
|
Joint SIU / European Association of Urology (EAU) Symposium
|
|
1300-1500
|
|
Master Videos: Complications in Minimally Invasive Urology and How to Handle?
Co-Chairs: Greg Boustead, South Africa / Ravindra Sabnis, India
|
|
Learning Objectives:
At the end of this session, the attendees should:
- Have a clear overview of scope, severity and management of potential complications in the context of where they practice urology around the globe
- Understand the principles of emergency intra-operative management, organ preservation and salvage.
- Recognition and prevention of intermediate and long term complications
- Principles of minimizing risk of litigation related to iatrogenic injuries
- Pre-operative counselling/Informed consent
- Incorporating the WHO Surgical Checklist into Endourology
- “Calling in the Cavalry” – don't be afraid to ask for help
|
|
1300-1500
|
|
International Neuro-Urology Society (INUS) Symposium
|
|
Learning Objectives:
- Understand the physiological mechanisms behind normal and abnormal voiding
- Review the impact of common neurologic diseases on bladder function
- Identify 5 key points for common treatment modalities used in neuro-urology
- Apply key knowledge in the management of example neurourology scenarios
|
|
1300-1500
|
|
Interactive Session: Global Young Consultants Forum: Shaping your Urology Career
Chair: Belthangady Monu Zeeshan Hameed, India
Co-Chairs: Gabriela Caballero, Mexico / Etienne Xavier Keller, Switzerland
|
|
1300-1700
|
|
Symposium on Focal Therapy for Renal and Prostate cancer
Co-Chairs: Jurgen Futterer, The Netherlands / Rafael Tourinho-Barbosa, Brazil
|
|
1500-1630
|
|
Instructional Course: Overcoming Access and Quality Barriers in Cancer Care using Disruptive Health Technologies
|
|
1500-1630
|
|
Instructional Course: Advanced Ureteroscopy
|
|
1500-1700
|
|
Hot Topics: Modern Endourological Avenues for Urologists
Co-Chairs: Madhu Agrawal, India / Ben Chew, Canada
|
|
1500-1700
|
|
Luncheon Symposium
|
|
1500-1700
|
|
Master Videos: Recent Innovations in Transurethral Techniques for Resection of Bladder Tumor
Co-Chairs: José Luis Domínguez-Escrig, Spain / Badrinath Konety, United States
|
|
1500-1700
|
|
SIU Tips and Tricks - Pt 3 SIU uCare
Chair: Laurence Klotz, Canada
|
|
1500-1700
|
|
Hellenic Urological Association (HUA) Symposium
Co-Chairs: Alivizatos Gerasimos, Greece / Ioannis Gkialas, Greece
|
|
Educational needs and expected educational outcomes:
- Participants are expected to learn from attending scientific presentations on bladder cancer explaining latest scientific data as well as addressing difficulties faced when treating bladder cancer patients.
- The session will provide insights for scientists into clinical application of their research, as well as for clinicians into the scientific basis of their technologies and treatments. Junior scientists and clinicians will get a unique insight into each other’s intertwined knowledge basis.
- Participants will learn how medical professionals apply elements of scientific methods to make critical observations on each patient, prepare accurate diagnoses and effectively treat bladder cancer.
- It is expected that attendees of the session will return to their practice with additional knowledge to treat their bladder cancer patients. They are expected to have improved skills while younger doctors and/or trainees are expected to feel more confident about their knowledge and skills after attending a session describing the latest issues in treating bladder cancer.
- Highlight commonalities (strengths) and gaps (opportunities for improvement) in our practice.
Promoting of active learning and learner engagement:
- Dedicated question and answer time during the sessions
- Opportunity for discussion/ audience participation during the session
- Opportunity for attendees to interact with experts in the field of bladder cancer and create an international consultation network which will enable them to have access to knowledge and improve their skills
|
|
|
|
1500-1700
|
|
EurAsian Urooncology Association (EUA) Symposium
|
